ConductScience.org, home

Paper37460259

Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.

Darlington P and 6 others. BMJ Open, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection. Papers, record 37460259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37460259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
PubMed
Journal
BMJ Open
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2023-07-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Darlington PPernillahttps://orcid.org/0000-0002-3411-8838
2Roël MMari
3Cronhjort MMaria
4Hanna GGabriel
5Hedman AAnders
6Joelsson-Alm EEva
7Schandl AAnna

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Quality of LifeMajor topic
COVID-19Major topic
Adult
Humans
Prospective Studies
Cohort Studies
Pandemics
Critical Illness
Intensive Care Units
Lung

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135024981
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands.
Ann Intensive Care2022https://conductscience.org/library/papers/35024981PubMed
23811032Reference values for lung function tests in men: regression equations with smoking variables.Ups J Med Sci1986https://conductscience.org/library/papers/3811032PubMed
334665518The role of ventilatory support for long-term outcomes after critical infection with COVID-19: A prospective cohort study.Clin Respir J2022https://conductscience.org/library/papers/34665518PubMed
434365975One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection.BMC Med2021https://conductscience.org/library/papers/34365975PubMed
534474056Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.J Infect2022https://conductscience.org/library/papers/34474056PubMed
6334288676-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet2021https://conductscience.org/library/papers/33428867PubMed
735393149The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.Vaccine2022https://conductscience.org/library/papers/35393149PubMed
825672277ICU survivors show no decline in health-related quality of life after 5 years.Intensive Care Med2015https://conductscience.org/library/papers/25672277PubMed
98275167The RAND 36-Item Health Survey 1.0.Health Econ1993https://conductscience.org/library/papers/8275167PubMed
1021470008Functional disability 5 years after acute respiratory distress syndrome.N Engl J Med2011https://conductscience.org/library/papers/21470008PubMed
1135695095From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?J Enzyme Inhib Med Chem2022https://conductscience.org/library/papers/35695095PubMed
1234751263Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study.Lancet Reg Health Eur2021https://conductscience.org/library/papers/34751263PubMed
1332678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
1435215212Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms.Pathogens2022https://conductscience.org/library/papers/35215212PubMed
1534548826A Second Wave? What Do People Mean by COVID Waves? - A Working Definition of Epidemic Waves.Risk Manag Healthc Policy2021https://conductscience.org/library/papers/34548826PubMed
1632017661CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV).Radiology2020https://conductscience.org/library/papers/32017661PubMed
1720956146Epidemiology of COPD.Eur Respir Rev2009https://conductscience.org/library/papers/20956146PubMed
1836065136How Sweden approached the COVID-19 pandemic: Summary and commentary on the National Commission Inquiry.Acta Paediatr2023https://conductscience.org/library/papers/36065136PubMed
1933119402Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis.Am J Respir Crit Care Med2021https://conductscience.org/library/papers/33119402PubMed
2029757320The Swedish RAND-36 Health Survey - reliability and responsiveness assessed in patient populations using Svensson's method for paired ordinal data.J Patient Rep Outcomes2017https://conductscience.org/library/papers/29757320PubMed

See all 45 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41788886Outcomes after specialized rehabilitation for patients with critical COVID-19 and prolonged intensive care unit stays.Eur Clin Respir J2026https://conductscience.org/library/papers/41788886PubMed
40696590The assessment of pulmonary impairment and clinical correlations in patients survived from SARS-CoV-2 infection: A 3-month follow-up study.Medicine (Baltimore)2025https://conductscience.org/library/papers/40696590PubMed
40287680Corticosteroids and long-term pulmonary function after critical illness due to COVID-19- a single-center cohort study.BMC Pulm Med2025https://conductscience.org/library/papers/40287680PubMed
39835287Self-reported health, persistent symptoms, and daily activities 2 years after hospitalization for COVID-19.Front Cell Neurosci2024https://conductscience.org/library/papers/39835287PubMed
38633311Residual radiological opacities correlate with disease outcomes in ICU-treated COVID-19.Front Med (Lausanne)2024https://conductscience.org/library/papers/38633311PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37460259

GET https://conductscience.org/api/papers/v1/37460259/references?page=2